'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages

Nature Immunology

Volumn 9, Issue 2, 2008, Pages 186-193

  Wang, Lu ^a   Tassiulas, Ioannis ^a,e   Park Min, Kyung Hyun ^a   Reid, Alicia C ^b   Gil Henn, Hava ^c   Schlessinger, Joseph ^c   Baron, Roland ^c   Zhang, Jillian J ^b   Ivashkiv, Lionel B ^a,d  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

^e UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; CALCIUM; CYTOKINE; CYTOKINE RECEPTOR; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF COUPLED RECEPTOR; INTERFERON; INTERLEUKIN 10; JANUS KINASE; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RECEPTOR; STAT1 PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELLS, CULTURED; FOCAL ADHESION KINASE 2; HUMANS; INTERFERON TYPE I; JANUS KINASES; MACROPHAGES; MICE; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TYROSINE;

EID: 38449093322     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1548     Document Type: Article

References (50)

1. Hamerman, J.A. & Lanier, L.L. Inhibition of immune responses by ITAM-bearing receptors. Sci STKE 2006, rel (2006).
2. Turnbull, I.R. & Colonna, M. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7, 155-161 (2007).
3. Underhill, D.M. & Goodridge, H.S. The many faces of ITAMs. Trends Immunol. 28, 66-73 (2007).
4. Asagiri, M. & Takayanagi, H. The molecular understanding of osteoclast differentiation. Bone 40, 251-264 (2007).
5. Hu, X., Chen, J., Wang, L. & Ivashkiv, L.B. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82, 237-243 (2007).
6. Tassiulas, I. et al. Amplification of IFN-α-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors. Nat. Immunol. 5, 1181-1189 (2004).
7. Abtahian, F. et al. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol. Cell. Biol. 26, 6936-6949 (2006).
8. Mocsai, A. et al. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs, Nat. Immunol. 7, 1326-1333 (2006).
9. 3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176, 877-888 (2007).
10. Bouchon, A., Facchetti, F., Weigand, M.A. & Colonna, M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410, 1103-1107 (2001).
11. Turnbull, I.R. et al. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 202, 363-369 (2005).
12. Hamerman, J.A. et al. Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051-2055 (2006).
13. Turnbull, I.R. et al. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520-3524 (2006).
14. Pasquier, B. et al. Identification of FcαRI as an inhibitory receptor that controls inflammation: Dual role of FcRγITAM. Immunity 22, 31-42 (2005).
15. Levy, D.E. & Darnell, J.E., Jr. STATs: Transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651-662 (2002).
16. 2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-γ. Proc. Natl. Acad. Sci. USA 99, 5971-5976 (2002).
17. Zhang, X., Blenis, J., Li, H.C., Schindler, C. & Chen-Kiang, S. Requirement of serine phosphorylation for formation of STAT-prornoter complexes. Science 267, 1990-1994 (1995).
18. van Boxel-Dezaire, A.H., Rani, M.R. & Stark, G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361-372 (2006).
19. Shuai, K. & Liu, B. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3, 900-911 (2003).
20. 2+/CaM-dependent kinases: From activation to function. Annu. Rev. Pharmacol. Toxicol. 41, 471-505 (2001).
21. Mocsai, A. et al. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl Acad. Sci. USA 101, 6158-6163 (2004).
22. Ho, H.H. & lvashkiv, L.B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281, 14111-14118 (2006).
23. Avraham, H., Park, S.Y., Schinkmann, K. & Avraham, S. RAFTK/ Pyk2-mediated cellular signalling. Cell. Signal. 12, 123-133 (2000).
24. Benbernou, N., Muegge, K. & Durum, S.K. Interleukin (IL)-7 induces rapid activation of Pyk2, which is bound to Janus kinase 1 and IL-7Rα. J. Biol. Chem. 275, 7060-7065 (2000).
25. 2*-induced regulation of ion channel and MAP kinase functions. Nature 376, 737-745 (1995).
26. Miyazaki, T. et al. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12, 770-775 (1998).
27. Takaoka, A. et al. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-γ, but not IFN-α, signaling. EMBO J. 18, 2480-2488 (1999).
28. Li, X., Hunter, D., Morris, J., Haskill, J.S. & Earip, H.S. A calcium-dependent tyrosine kinase splice variant in human monocytes. Activation by a two-stage process involving adherence and a subsequent intracellular signal. J. Biol. Chem. 273, 9361-9364 (1998).
29. Okigaki, M. et al. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc. Natl. Acad. Sci. USA 100, 10740-10745 (2003).
30. 3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J. cell Biol. 152, 181-195 (2001).
31. Briscoe, J. et al. Kinaise-negative mutants of JAK1 can sustain interferon-γ-inducible gene expression but not an antiviral state. EMBO J. 15, 799-809 (1996).
32. Gauzzi, M.C. et al. Interferon-α-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem. 271, 20494-20500 (1996).
33. Li, X., Leung, S., Kerr, I.M. & Stark, G.R. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol. Cell. Biol. 17, 2048-2056 (1997).
34. 2+ response amplitude and duration. Nature 386, 855-858 (1997).
35. Healy, J.I. et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6, 419-428 (1997).
36. Mocsai, A., Zhou, M., Meng, F, Tybulewicz, V.L. & Lowell, C.A. Syk is required for integrin signaling in neutrophils. Immunity 16, 547-558 (2002).
37. Berridge, M.J. Inositol trisphosphate and calcium signalling. Nature 361, 315-325 (1993).
38. Andreev, J. et al. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276, 20130-20135 (2001).
39. Fischer, O.M., Hart, S., Gschwind, A. & Ullrich, A. EGFR signal transactivation in cancer cells. Biochem, Soc. Trans. 31, 1203-1208 (2003).
40. Baccala, R., Hoebe, K., Kono, D.H., Beutler, B. & Theofilopoulos, A. N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13, 543-551 (2007).
41. Ivashkiv, L.B. Type I interferon modulation of cellular responses to cytokines and infectious pathogens: Pntential role in SLE pathogenesis. Autoimmunity 36, 473-479 (2003).
42. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002).
43. 2+/calmodulin-dependent kinase II. J. Biol. Chem. 280, 24212-24220 (2005).
44. Ginnan, R. & Singer, H.A. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 282, C754-C761 (2002).
45. Han, H., Fuortes, M. & Nathan, C. Critical role of the carboxyl terminus of proline-rich tyrosine kinase (Pyk2) in the activation of human neutrophils by tumor necrosis factor: Separation of signals for the respiratory burst and degranulation. J. Exp. Med. 197, 63-75 (2003).
46. Shi, C.S. & Kehrl, J.H. Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation. J. Biol. Chem. 279, 17224-17231 (2004).
47. DLP, Z. et al. Selective regulation of IL-10 signaling and function by zymosan. J. Immunol. 176, 4785-4792 (2006).
48. Ji J.D. et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. 197, 1573-1583 (2003).
49. Dhodapkar, K.M. et al. Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J. Exp. Med. 204, 1359-1369 (2007).
50. Miyazaki, T. et al. Src kinase activity is essential for ostecclast function. J. Biol. Chem. 279, 17660-17666 (2004).